RA Capital Nexus Fund, L.P.
Director · 22 filings · Latest: Sep 28, 2026
Artiva Biotherapeutics, Inc.
Climb Bio, Inc.
Freenome, Inc.
Nkarta, Inc.
Sionna Therapeutics, Inc.
Tyra Biosciences, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
ARTV | RA Capital Nexus Fund, L.P. | Director | Jun 9, 2026 | Purchase | $6.91 | 479,039 | $3.3M | 15,683,034 | |
ARTV | RA Capital Nexus Fund, L.P. | Director | May 11, 2026 | Purchase | $11.52 | 6,510,416 | $75.0M | 15,203,995 | |
SION | RA Capital Nexus Fund, L.P. | — | Nov 21, 2025 | Proposed Sale | $43.66 | 9,924 | $433.3K | — | |
SION | RA Capital Nexus Fund, L.P. | — | Nov 20, 2025 | Proposed Sale | $38.94 | 2,023 | $78.8K | — | |
SION | RA Capital Nexus Fund, L.P. | — | Nov 19, 2025 | Proposed Sale | $38.41 | 18,696 | $718.1K | — | |
SION | RA Capital Nexus Fund, L.P. | — | Nov 18, 2025 | Proposed Sale | $39.04 | 2,728 | $106.5K | — | |
SION | RA Capital Nexus Fund, L.P. | — | Nov 17, 2025 | Proposed Sale | $39.93 | 32,310 | $1.3M | — | |
SION | RA Capital Nexus Fund, L.P. | — | Oct 28, 2025 | Proposed Sale | $39.45 | 31,392 | $1.2M | — | |
SION | RA Capital Nexus Fund, L.P. | — | Oct 24, 2025 | Proposed Sale | $39.21 | 122,271 | $4.8M | — | |
VOR | RA Capital Nexus Fund, L.P. | — | Oct 20, 2025 | Proposed Sale | $29.43 | 15,104 | $444.5K | — | |
VOR | RA Capital Nexus Fund, L.P. | — | Oct 17, 2025 | Proposed Sale | $29.00 | 42,816 | $1.2M | — | |
VOR | RA Capital Nexus Fund, L.P. | — | Oct 16, 2025 | Proposed Sale | $29.06 | 24,916 | $724.1K | — | |
VOR | RA Capital Nexus Fund, L.P. | — | Oct 15, 2025 | Proposed Sale | $30.22 | 8,430 | $254.8K | — |
← Previous
Page 2 of 2